{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:46:24Z","timestamp":1791733584882,"version":"4.3.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-17134-4","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:36:22Z","timestamp":1791686182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic interpretation of CFH expression in pan-cancer analyses: the importance of factor H\u2013like 1 isoform resolution"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-8355","authenticated-orcid":false,"given":"Simon J.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"key":"17134_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-025-15491-0","author":"X Zheng","year":"2025","unstructured":"Zheng X, Lv C, Guo X. Comprehensive cancer analysis reveals CFH as an immune-related and prognostic marker. BMC Cancer 2025. 2025. https:\/\/doi.org\/10.1186\/S12885-025-15491-0.","journal-title":"BMC Cancer 2025"},{"key":"17134_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/IMR.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, M\u00e1rquez-Tirado B, Goicoechea de Jorge E. The Factor H protein family: The switchers of the complement alternative pathway. Immunol Rev. 2023;313:25\u201345. https:\/\/doi.org\/10.1111\/IMR.13166.","journal-title":"Immunol Rev"},{"key":"17134_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/IJO.2011.1010\/ABSTRACT","volume":"39","author":"T Cui","year":"2011","unstructured":"Cui T, Chen Y, Kn\u00f6sel T, Yang L, Z\u00f6ller K, Galler K, et al. Human complement factor H is a novel diagnostic marker for lung adenocarcinoma. Int J Oncol. 2011;39:161\u20138. https:\/\/doi.org\/10.3892\/IJO.2011.1010\/ABSTRACT.","journal-title":"Int J Oncol"},{"key":"17134_CR4","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1158\/0008-5472.CAN-03-2328","volume":"64","author":"D Ajona","year":"2004","unstructured":"Ajona D, Casta\u00f1o Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, et al. Expression of Complement Factor H by Lung Cancer CellsEffects on the Activation of the Alternative Pathway of Complement. Cancer Res. 2004;64:6310\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2328.","journal-title":"Cancer Res"},{"key":"17134_CR5","doi-asserted-by":"publisher","first-page":"1135490","DOI":"10.3389\/FIMMU.2024.1135490\/XML\/NLM","volume":"15","author":"N S\u00e1ndor","year":"2024","unstructured":"S\u00e1ndor N, Schneider AE, Matola AT, Barbai VH, Bencze D, Hammad HH, et al. The human factor H protein family \u2013 an update. Front Immunol. 2024;15:1135490. https:\/\/doi.org\/10.3389\/FIMMU.2024.1135490\/XML\/NLM.","journal-title":"Front Immunol"},{"key":"17134_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-017-0649-6","volume":"40","author":"SJ Clark","year":"2018","unstructured":"Clark SJ, Bishop PN. The eye as a complement dysregulation hotspot. Semin Immunopathol. 2018;40:65\u201374. https:\/\/doi.org\/10.1007\/s00281-017-0649-6.","journal-title":"Semin Immunopathol"},{"key":"17134_CR7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-1392","author":"L Zhai","year":"2021","unstructured":"Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Nguyen B, et al. Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma. Clin Cancer Res. 2021. https:\/\/doi.org\/10.1158\/1078-0432.ccr-21-1392.","journal-title":"Clin Cancer Res"},{"key":"17134_CR8","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.4049\/jimmunol.1401613","volume":"193","author":"SJ Clark","year":"2014","unstructured":"Clark SJ, Schmidt CQ, White AM, Hakobyan S, Morgan BP, Bishop PN. Identification of Factor H\u2013like Protein 1 as the Predominant Complement Regulator in Bruch\u2019s Membrane: Implications for Age-Related Macular Degeneration. J Immunol. 2014;193:4962\u201370. https:\/\/doi.org\/10.4049\/jimmunol.1401613.","journal-title":"J Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-17134-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:01:43Z","timestamp":1791730903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-17134-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["17134"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-17134-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1214"}}